Drugs / MK-8351
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01926002 | Sep 2013 → Apr 2014 | asthma | Merck Sharp & Dohme LLC | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK-8351 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01926002 ↗ |
| Route | Inhaled | “single inhaled dose” NCT01926002 ↗ |